We have located links that may give you full text access.
Asthma drugs and the risk of congenital anomalies.
Pharmacotherapy 2013 April
STUDY OBJECTIVE: To estimate the prevalence of congenital anomalies between the offspring of women exposed and unexposed to asthma drugs during early pregnancy.
DESIGN: Matched cohort study.
DATABASE: The United Kingdom's General Practice Research Database.
PATIENTS: Women exposed to asthma drugs during early pregnancy and a sample of matched unexposed pregnant women.
MEASUREMENTS AND MAIN RESULTS: The prevalence of any anomaly among unexposed and exposed women was 27.8 (95% confidence interval [CI] 25.4-30.6)/1000 pregnancies and 31.3 (95% CI 27.7-35.5)/1000 pregnancies, respectively (relative risk [RR] 1.1 95% CI 1.0-1.3).
CONCLUSION: Our findings suggest that asthma drugs, overall, do not increase the risk of congenital anomalies in the offspring when taken during the first trimester of pregnancy.
DESIGN: Matched cohort study.
DATABASE: The United Kingdom's General Practice Research Database.
PATIENTS: Women exposed to asthma drugs during early pregnancy and a sample of matched unexposed pregnant women.
MEASUREMENTS AND MAIN RESULTS: The prevalence of any anomaly among unexposed and exposed women was 27.8 (95% confidence interval [CI] 25.4-30.6)/1000 pregnancies and 31.3 (95% CI 27.7-35.5)/1000 pregnancies, respectively (relative risk [RR] 1.1 95% CI 1.0-1.3).
CONCLUSION: Our findings suggest that asthma drugs, overall, do not increase the risk of congenital anomalies in the offspring when taken during the first trimester of pregnancy.
Full text links
Related Resources
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app